U.S. flag An official website of the United States government
  1. Home
  2. Emergency Preparedness and Response
  3. Counterterrorism and Emerging Threats
  4. Coronavirus Disease 2019 (COVID-19)
  5. Janssen COVID-19 Vaccine
  1. Coronavirus Disease 2019 (COVID-19)

Janssen COVID-19 Vaccine

April 13, 2021: Out of an abundance of caution, the FDA and CDC recommended a pause in the use of the Johnson & Johnson (Janssen) COVID-19 vaccine while we review data from six reported cases in the U.S. of a rare and severe type of blood clot in people who received the vaccine. View frequently asked questions

Report vaccine side effects toll-free at 1-800-822-7967 or online to FDA/CDC Vaccine Adverse Event Reporting System (VAERS).

On February 27, 2021, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older.


Emergency Use Authorization Status:
Authorized
Name:
Janssen COVID-19 Vaccine
Manufacturer:
Janssen Biotech Inc.,
a Janssen Pharmaceutical Company of Johnson & Johnson

Authorized Use

For the prevention of coronavirus disease 2019 (COVID-19) for individuals 18 years of age and older

Common Side Effects

The most commonly reported side effects were pain at the injection site, headache, fatigue, muscle aches and nausea. Most of these side effects occurred within 1-2 days following vaccination and were mild to moderate in severity and lasted 1-2 days. Learn more.

Additional Information

Translations of the Fact Sheet for Recipients and Caregivers

Fact Sheet Language
بيان حقائق لمتلقي ومقدمي الرعاية الصحية عربي (Arabic)
প্রাপক এবং সেবাপ্রদানকারীদের জন্য তথ্য পত্র ইংরেজী (Bengali)
ကာကွယ်ဆေး လက်ခံရရှိသူများနှင့် စောင့်ရှောက်မှု ပေးသူများအတွက် သတင်းအချက်အလက် စာရွက် မြန်မာ (Burmese)
接受者和护理者须知 中文 (Chinese, Simplified)
ᎤᏙᎯᏳ ᎪᏪᎳᏅ ᎾᏍᎩᎾ ᏗᏂᏁᏍᎩ ᎠᎴ ᎤᎾᏓᎦᏎᏍᏗ ᏗᎾᏓᏍᏕᎵᏍᎩ ᎩᎵᏏ (Cherokee)
TAROPWEN AFFAT (IKA FACT SHEET) REN CHON ANGEI ME CHON TUMUN Foosun Chuuk (Chuukese)
برگه اطلاعات برای دریافت کنندگان و ارائه کنندگان مراقبت فارسی (Farsi)
FICHE D'INFORMATION POUR LES BÉNÉFICIAIRES ET LES AIDANTS Français (French)
MERKBLATT FÜR EMPFÄNGER UND BETREUER Deutsch (German)
પ્રાપ્તિકર્તા અને સંભાળ રાખનારાઓ માટે તથ્ય શીટ ગુજરાતી (Gujarati)
FEY ENFOMASYON POU MOUN K’AP RESEVWA AVEK MOUN K’AP BAY SWEN Kreyòl Ayisyen (Haitian Creole)
प्राप्तकर्ताओं और देखभाल कर्ताओं के लिए तथ्य पत्र/फैक्ट शीट हिन्दी (Hindi)
DAIM NTAWV QHIA TSEEB RAU COV NEEG TAU KEV PAB THIAB COV NEEG ZOV TU Hmoob (Hmong)
SCHEDA INFORMATIVA PER RICEVENTI E ASSISTENTI Italiano (Italian)
ワクチン接種を受ける人と介護従事者のためのファクトシート 日本 (Japanese)
បញ្ជីហេតុការណ៍សម្រាប់អ្នកទទួលនិងអ្នកថែរទាំ ភាសាអង់គ្លេស (Khmer)
환자와 의료진을 위한 정보지 한국어 (Korean)
PEBA IN KŌMEḶEḶE ÑAN RO REJ BŌK WĀ IM RO REJ LALE RO RE NAÑINMEJ Pālle (Marshallese)
BAA ÁDAHWIILYÁNÍÍ DÓÓ BÁ ADAHAZT’I’ÍÍ NAALTSOOS BEE ÉÉHÓZINÍÍ ÁT’É Bilagáanaa Bizaad jí (Navajo)
ARKUSZ INFORMACYJNY DLA OSÓB SZCZEPIONYCH I ICH OPIEKUNÓW Polski (Polish)
FICHA TÉCNICA PARA BENEFICIÁRIOS E PROFISSIONAIS DE SAÚDE Português (Portuguese)
ИНФОРМАЦИОННЫЙ БЮЛЛЕТЕНЬ ДЛЯ РЕЦИПИЕНТОВ И СПЕЦИАЛИСТОВ ПО УХОДУ Русский (Russian)
XAASHIDA MACLUUMAADKA EE LOOGU TALAGALAY TALLAAL QAATAYAASHA IYO DARYEELAYAASHA Soomaali (Somali)
HOJA INFORMATIVA PARA RECEPTORES Y PROVEEDORES DE CUIDADO Español (Spanish)
FACT SHEET PARA SA MGA TATANGGAP AT MGA TAGAPAG-ALAGA Tagalog (Tagalog)
TỜ THÔNG TIN CHO NGƯỜI NHẬN VÀ NHỮNG NGƯỜI CHĂM SÓC Tiếng Việt (Vietnamese)
אינפאָרמאַציע בלאט פאר די וועלכע באקומען די וואַקסין און פאר געהילפן (גבאים) אידיש (Yiddish)
Back to Top